JUVENTAS
Juventas is a provider and developer of innovative immune cell therapeutic drugs. The company's first investigational new drug application for the cell therapeutic product CNCT19 has been officially accepted by the National Medical Products Administration. Comprehensive product pipelines will be developed and promoted constantly to provide effective treatment for malignant hematological neoplasms such as leukemia and lymphoma.
JUVENTAS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
Chaoyang, Liaoning, China
Country:
China
Website Url:
http://www.juventas.cn
Total Employee:
11+
Status:
Active
Contact:
010-65960098
Email Addresses:
[email protected]
Total Funding:
101.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Microsoft Azure DNS PHP PHP 7 Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style
Current Employees Featured
Founder
Investors List
Ding Xiang Capital
Ding Xiang Capital investment in Series C - Juventas
Dalton Venture
Dalton Venture investment in Series C - Juventas
Delian Capital
Delian Capital investment in Series C - Juventas
CICC
CICC investment in Series C - Juventas
Redhill Capital
Redhill Capital investment in Series C - Juventas
Jiadao Capital
Jiadao Capital investment in Series C - Juventas
Haisong Capital
Haisong Capital investment in Series C - Juventas
Tianchuang Zhixing (Beijing) Touzi Guanli Zixun Youxian Gongsi
Tianchuang Zhixing (Beijing) Touzi Guanli Zixun Youxian Gongsi investment in Series C - Juventas
Tianjin Venture Capital
Tianjin Venture Capital investment in Venture Round - Juventas
CASI Pharmaceuticals
CASI Pharmaceuticals investment in Series A - Juventas
